Invesco Ltd. G1 Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.2 - $4.98 $78,559 - $177,830	35,709 New	35,709 $81,000
Q3 2023 Nov 13, 2023	BUY	$1.22 - $2.67 $8,261 - $18,081	6,772 Added 48.63%	20,697 $29,000
Q2 2023 Aug 11, 2023	BUY	$2.46 - $3.14 $2,484 - $3,171	1,010 Added 7.82%	13,925 $34,000
Q1 2023 May 12, 2023	BUY	$2.57 - $8.16 $4,600 - $14,606	1,790 Added 16.09%	12,915 $34,000
Q4 2022 Feb 13, 2023	SELL	$5.19 - $13.5 $529,047 - $1.38 Million	-101,936 Reduced 90.16%	11,125 $60,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $584,525 - $1.92 Million	113,061 New	113,061 $1.41 Million
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $65,076 - $137,079	-16,108 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $65,063 - $94,342	-8,561 Reduced 34.7%	16,108 $122,000
Q4 2021 Feb 14, 2022	SELL	$10.16 - $16.17 $22,971 - $36,560	-2,261 Reduced 8.4%	24,669 $252,000
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $35,742 - $61,028	2,716 Added 11.22%	26,930 $362,000
Q2 2021 Aug 17, 2021	BUY	$19.57 - $26.32 $115,599 - $155,472	5,907 Added 32.27%	24,214 $531,000
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $11.6 Million - $21.4 Million	-657,173 Reduced 97.29%	18,307 $441,000
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $3.82 Million - $7.1 Million	347,896 Added 106.2%	675,480 $12.2 Million
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $978,030 - $2.01 Million	84,678 Added 34.86%	327,584 $3.78 Million
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $255,289 - $650,094	-26,676 Reduced 9.9%	242,906 $5.89 Million
Q1 2020 May 15, 2020	BUY	$9.07 - $26.32 $337,131 - $978,314	37,170 Added 15.99%	269,582 $2.97 Million
Q4 2019 Feb 14, 2020	SELL	$20.54 - $31.0 $303,992 - $458,800	-14,800 Reduced 5.99%	232,412 $6.14 Million
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $4.73 Million - $8.43 Million	207,790 Added 527.09%	247,212 $5.63 Million
Q2 2019 Aug 14, 2019	SELL	$16.03 - $31.1 $496,946 - $964,131	-31,001 Reduced 44.02%	39,422 $1.21 Million
Q1 2019 May 15, 2019	BUY	$14.4 - $21.45 $537,220 - $800,235	37,307 Added 112.66%	70,423 $1.17 Million
Q4 2018 Feb 14, 2019	BUY	$16.51 - $51.33 $546,745 - $1.7 Million	33,116 New	33,116 $634,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account